Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000803306 | SCV000943170 | uncertain significance | Hereditary spastic paraplegia 28 | 2022-08-10 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 648556). This variant has not been reported in the literature in individuals affected with DDHD1-related conditions. This variant is present in population databases (rs771632283, gnomAD 0.06%). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 89 of the DDHD1 protein (p.Tyr89Cys). |
Genome Diagnostics Laboratory, |
RCV001849105 | SCV002104591 | uncertain significance | Hereditary spastic paraplegia | 2019-03-01 | criteria provided, single submitter | clinical testing |